Browse > Article
http://dx.doi.org/10.22889/KJP.2020.51.2.107

Anti-inflammatory Effect of p-Hydroxycinnamic Acid on HT-29 Intestinal Cells and Its Therapeutic Effect of Immune Bowel Disease  

Lee, Hyun-Su (College of Pharmacy, Keimyung University)
Lee, Seung-Ho (College of Pharmacy, Yeungnam University)
Choi, Hyukjae (College of Pharmacy, Yeungnam University)
Jeong, Gil-Saeng (College of Pharmacy, Keimyung University)
Publication Information
Korean Journal of Pharmacognosy / v.51, no.2, 2020 , pp. 107-114 More about this Journal
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder on the large intestine that has been considered as an incurable not only in Western society but also in Eastern Asia in recent years. Despite enormous efforts to develop novel therapeutics for this disease, strategy using bioactive compounds from natural product is still considered as important. p-hydroxycinnamic acid (HCA) is an intermediate substance found in several plants and has been known to possess anti-inflammation but little evidence is reported whether HCA has an inhibitory effect on intestinal inflammation. In the present study, we observed HCA does not show cytotoxic and apoptotic in HT-29 cells. Quantitative PCR analysis revealed that HCA effectively blocks the activity of HT-29 cells stimulated with TNF-α treatment. HCA inhibits translocation of p65 and MAPK pathways in activated HT-29 cells by TNF-α treatment. Besides, oral administration of HCA attenuates manifestation of DSS-induced inflammatory disease in vivo. Histological analysis exhibited that oral administration of HCA recovers IBD symptoms. The expression of pro-inflammatory cytokines were reduced by oral administration of HCA on intestinal tissues. Therefore, these results suggest that HCA has a potent anti-inflammatory effect on intestinal cells as well as show a therapeutic potential for treating IBD in vivo.
Keywords
p-Hydroxycinnamic acid; HT-29; $TNF-{\alpha}$; MAPK; Immune bowel disease; Anti-inflammation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Choi, E. J., Lee, H. J., Kim, W. J., Han, K. I., Iwasa, M., Kobayashi, K., Debnath, T., Tang, Y., Kwak, Y. S., Yoon, J. H. and Kim, E. K. (2019) Enterococcus faecalis EF-2001 protects DNBS-induced inflammatory bowel disease in mice model. PLoS One 14: e0210854.   DOI
2 Kaser, A., Zeissig, S. and Blumberg, R. S. (2010) Inflammatory Bowel Disease. Annu. Rev. Immunol. 28: 573-621.   DOI
3 Horsthuis, K., Stokkers, P. C. F. and Stoker, J. (2008) Detection of inflammatory bowel disease: Diagnostic performance of cross-sectional imaging modalities. Abdom. Imaging 33: 407-416.   DOI
4 Baumgart, D. C. and Sandborn, W. J. (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.   DOI
5 Moldoveanu, A. C., Diculescu, M. and Braticevici, C. F. (2015) Cytokines in inflammatory bowel disease. Rom. J. Intern. Med. 53: 118-127.
6 Klampfer, L. (2011) Cytokines, Inflammation and Colon Cancer. Curr. Cancer Drug Targets 11: 451-464.   DOI
7 Romani, A., Vignolini, P., Isolani, L., Ieri, F. and Heimler, D. (2006) HPLC-DAD/MS characterization of flavonoids and hydroxycinnamic derivatives in turnip tops(Brassica rapa L. Subsp. sylvestris L.). J. Agric. Food Chem. 54: 1342-1346.   DOI
8 Zhao, Z., Egashira, Y. and Sanada, H. (2005) Phenolic antioxidants richly contained in corn bran are slightly bioavailable in rats. J. Agric. Food Chem. 53: 5030-5035.   DOI
9 Pragasam, S. J., Venkatesan, V. and Rasool, M. (2013) Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats. Inflammation 36: 169-176.   DOI
10 Lee, H. S., Kim, Y. D., Na, B. R., Kim, H. R., Choi, E. J., Han, W. C., Choi, H. K., Lee, S. H. and Jun, C. D. (2012) Phytocomponent p-Hydroxycinnamic acid inhibits T-cell activation by modulation of protein kinase C-${\theta}$-dependent pathway. Int. Immunopharmacol. 12: 131-138.   DOI
11 Lee, H. S., Choi, E. J., Lee, K. S., Kim, H. R., Na, B. R., Kwon, M. S., Jeong, G. S., Choi, H. G., Choi, E. Y. and Jun, C. D. (2016) Oral Administration of p-hydroxycinnamic acid attenuates atopic dermatitis by downregulating Th1 and Th2 cytokine production and keratinocyte activation. PLoS One 11: e0150952.   DOI
12 Kessler, S. P., Obery, D. R. and De La Motte, C. (2015) Hyaluronan synthase 3 null mice exhibit decreased intestinal inflammation and tissue damage in the DSS-induced colitis model. Int. J. Cell Biol. 2015: 745237.   DOI
13 Kim, S., Domon-Dell, C., Kang, J., Chung, D. H., Freund, J. N. and Evers, B. M. (2004) Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-${\alpha}$/nuclear factor-${\kappa}B$(NF-${\kappa}B$)-inducing kinase/ NF-${\kappa}B$ pathway is linked to a default $I{\kappa}B$-${\alpha}$ autoregulatory loop. J. Biol. Chem. 279: 4285-4291.   DOI
14 Gross, V., Andus, T., Daig, R., Aschenbrenner, E., Scholmerich, J. and Falk, W. (1995) Regulation of interleukin-8 production in a human colon epithelial cell line(HT-29). Gastroenterology 108: 653-661.   DOI
15 Zheng, Z., Jiang, H., Huang, Y., Wang, J., Qiu, L., Hu, Z., Ma, X. and Lu, Y. (2016) Screening of an anti-inflammatory peptide from Hydrophis cyanocinctus and analysis of its activities and mechanism in DSS-induced acute colitis. Sci. Rep. 6: 25672.   DOI
16 Williams, C., Panaccione, R., Ghosh, S. and Rioux, K. (2011) Optimizing clinical use of mesalazine(5-aminosalicylic acid) in inflammatory bowel disease. Ther. Adv. Gastroenterol. 4: 237-248.   DOI